September 16, 2025

Lebrikizumab 24-Week Trial in Skin of Color Atopic Dermatitis

Lebrikizumab shows sustained efficacy across Fitzpatrick IV–VI at 24 weeks in atopic dermatitis.

Conexiant

September 12, 2025

Maternal Health and Vitiligo: First Scoping Review Protocol

Protocol outlines review of vitiligo pregnancy outcomes, methods, and planned data mapping.

Conexiant

September 09, 2025

Top 10 States to Practice Dermatology

The following list highlights the states that offer the most favorable conditions for dermatologists.

Conexiant

April 30, 2024

Improving Measurement of Postinflammatory Hyperpigmentation With Novel Scale

Researchers have developed a scale to assess postinflammatory hyperpigmentation.

Conexiant

January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant

September 17, 2024

Can Hair Dye Cause Retinopathy?

Aromatic amines may cause long-term RPE dysfunction

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

July 31, 2024

Alopecia Areata Linked to Mental, Autoimmune Risks

New study published in JAMA Dermatology reveals that patients newly diagnosed with alopecia areata face a higher risk of developing psychiatric and autoimmune disorders.

Conexiant

April 01, 2025

Evaluating Sentinel Node Positivity in Melanoma

A systematic review and meta-analysis identified 21 risk prediction models for sentinel lymph node biopsy positivity in melanoma, revealing a pooled C statistic of 0.78 and highlighting the need for further research to optimize their clinical implementation.

Conexiant